Skip to content
Trial Agents

Emb Statistical Solutions

Emb Statistical Solutions is recorded as a service provider in 5 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.

5distinct trials
3recorded service labels
0trials with learnings

Data snapshot: 2026-10-09 · About the data

Clinical trial experience

Showing 5 of 5 trials · Latest update first

A Phase 3, Randomized, Double-blind, Placebo‑controlled Study to Assess the Efficacy and Safety of Engasertib in Subjects With Moderate to Severe Hereditary Hemorrhagic Telangiectasia (HHT)

Sponsor Vaderis Therapeutics AG

Start (EU)
Latest update
Estimated end

A Phase 3, randomized, double-blind, double-dummy, multicenter, multinational study to assess the efficacy and safety of orally administered tebipenem pivoxil hydrobromide (TBP-PI-HBr) compared to intravenously (IV) administered imipenem-cilastatin in patients with complicated urinary tract infection (cUTI) or acute pyelonephritis (AP)

Sponsor Spero Therapeutics Inc.

Start (EU)
Latest update
Estimated end

Questions about this trial experience

What services are recorded for Emb Statistical Solutions?

The 2026-10-09 snapshot links Emb Statistical Solutions to 5 distinct CTIS trials. Recorded services include Statistical analysis, Data management, Statistical Analysis (blinded). These are study-specific roles, not a complete or independently verified capability catalogue.

Which therapeutic areas and study phases are recorded for Emb Statistical Solutions?

The most frequently recorded therapeutic areas are Blood Disorders, Gastroenterology, Genetic and Congenital Disorders, Otolaryngology. Recorded phases include Phase 1, Phase 2, Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.

In which countries are trials linked to Emb Statistical Solutions conducted?

The linked trials record locations in 20 countries, including Belgium, Bulgaria, Germany, Spain, France. These are trial locations, not confirmed office locations or countries where Emb Statistical Solutions delivered services.

What can this page tell me about Emb Statistical Solutions's trial experience?

Browse 5 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.

About this data & company names

One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.

Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.

Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Emb Statistical Solutions. Legacy brands remain separate unless explicitly matched in the name registry.

View recorded company names
  • Emb Statistical Solutions LLC

Never miss a new clinical trial insight

We continuously analyze new and updated clinical trial data and publish practical, evidence-led reports for clinical leaders.